Vivo Capital Fund IX, L.P.
Insider CIK 1750117 · SRRA Director, 10% owner · TIL 10% owner · ALXO 10% owner · TARS 10% owner · IOBT 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| IOBT IO Biotech, Inc. | P Buy deriv | 2023-08-09 | 2023-08-10 | 3,157,894 | $0.13 | $410.5K | 3,157,894 | SEC↗ |
| IOBT IO Biotech, Inc. | P Buy | 2023-08-09 | 2023-08-10 | 3,157,894 | $1.90 | $6.00M | 3,157,894 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 75,749 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 324,740 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,455,384 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 2,735,853 | $55.00 | $150.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 431,947 | $55.00 | $23.76M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 161,712 | $55.00 | $8.89M | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-05-05 | 2022-05-05 | 5,374 | $12.25 | $65.8K | 2,469,001 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-05-04 | 2022-05-04 | 19,738 | $12.67 | $250.1K | 2,474,375 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-05-03 | 2022-05-04 | 451,418 | $13.25 | $5.98M | 2,494,113 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2022-05-02 | 2022-05-04 | 41,800 | $15.19 | $634.9K | 2,945,531 | SEC↗ |
| SRRA Sierra Oncology, Inc. | P Buy | 2022-01-31 | 2022-01-31 | 800,000 | $27.00 | $21.60M | 2,735,853 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 1,455,384 | $13.20 | $19.21M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 324,740 | $13.20 | $4.29M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 75,749 | $13.20 | $999.9K | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 107,164 | $13.20 | $1.41M | 431,947 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 24,996 | $13.20 | $329.9K | 161,712 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 480,277 | $13.20 | $6.34M | 1,935,853 | SEC↗ |
| IOBT IO Biotech, Inc. | C Conversion deriv | 2021-11-09 | 2021-11-12 | 188,168 | — | $0 | 0 | SEC↗ |
| IOBT IO Biotech, Inc. | P Buy | 2021-11-09 | 2021-11-12 | 650,000 | $14.00 | $9.10M | 3,015,545 | SEC↗ |
| IOBT IO Biotech, Inc. | C Conversion | 2021-11-09 | 2021-11-12 | 2,365,545 | — | $0 | 2,365,545 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-06-25 | 2021-06-25 | 7,704 | $29.60 | $228.0K | 2,987,331 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-06-24 | 2021-06-25 | 10,000 | $29.90 | $299.0K | 2,995,035 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-06-23 | 2021-06-25 | 37,980 | $29.80 | $1.13M | 3,005,035 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-06-22 | 2021-06-25 | 110,000 | $28.50 | $3.13M | 3,043,015 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-06-21 | 2021-06-25 | 91,620 | $29.70 | $2.72M | 3,153,015 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | S Sale | 2021-04-14 | 2021-04-16 | 400 | $30.37 | $12.1K | 3,244,635 | SEC↗ |
| TIL Instil Bio, Inc. | C Conversion deriv | 2021-03-23 | 2021-03-25 | 9,758,080 | — | $0 | 0 | SEC↗ |
| TIL Instil Bio, Inc. | C Conversion deriv | 2021-03-23 | 2021-03-25 | 397,576 | — | $0 | 0 | SEC↗ |
| TIL Instil Bio, Inc. | P Buy | 2021-03-23 | 2021-03-25 | 300,000 | $20.00 | $6.00M | 12,486,787 | SEC↗ |
| TIL Instil Bio, Inc. | C Conversion | 2021-03-23 | 2021-03-25 | 477,091 | — | $0 | 12,186,787 | SEC↗ |
| TIL Instil Bio, Inc. | C Conversion | 2021-03-23 | 2021-03-25 | 11,709,696 | — | $0 | 11,709,696 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion deriv | 2020-10-20 | 2020-10-20 | 2,780,754 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion deriv | 2020-10-20 | 2020-10-20 | 214,281 | — | $0 | 0 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion | 2020-10-20 | 2020-10-20 | 214,281 | — | $0 | 2,995,035 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | C Conversion | 2020-10-20 | 2020-10-20 | 2,780,754 | — | $0 | 2,780,754 | SEC↗ |
| TARS Tarsus Pharmaceuticals, In | P Buy | 2020-10-20 | 2020-10-20 | 250,000 | $16.00 | $4.00M | 3,245,035 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion deriv | 2020-07-21 | 2020-07-21 | 3,158,851 | — | $0 | 0 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 185,526 | $19.00 | $3.52M | 185,526 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | C Conversion | 2020-07-21 | 2020-07-21 | 3,245,048 | — | $0 | 4,034,522 | SEC↗ |
| ALXO ALX ONCOLOGY HOLDINGS INC | P Buy | 2020-07-21 | 2020-07-21 | 789,474 | $19.00 | $15.00M | 789,474 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 1,000 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 4,287 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 19,213 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 1,455,576 | — | $0 | 1,455,576 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 324,783 | — | $0 | 324,783 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 75,759 | — | $0 | 136,715 | SEC↗ |